Showing results (41-50 of 87) with videos related to
Sort By:
Pageof 9
Antiviral Research|June 7, 2011
Inhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivoRuth Pinto, Susanne Herold, Lidija Cakarova, et al.Journal of Virology|September 27, 2003
Borna disease virus nucleoprotein interacts with the CDC2-cyclin B1 complexOliver Planz, Stephan Pleschka, Katja Oesterle, et al.Vaccine|October 14, 2008
Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strainKaroline Droebner, Emanuel Haasbach, Cordula Fuchs, et al.The EMBO Journal|May 30, 2003
Caspase 3 activation is essential for efficient influenza virus propagationWalter J Wurzer, Oliver Planz, Christina Ehrhardt, et al.FEBS Letters|March 12, 2004
MEK inhibition impairs influenza B virus propagation without emergence of resistant variantsStephan Ludwig, Thorsten Wolff, Christina Ehrhardt, et al.The American Journal of Pathology|August 25, 2009
Spread of infection and lymphocyte depletion in mice depends on polymerase of influenza virusGülsah Gabriel, Karin Klingel, Oliver Planz, et al.Antiviral Research|July 23, 2011
Antiviral activity of the proteasome inhibitor VL-01 against influenza A virusesEmanuel Haasbach, Eva-Katharina Pauli, Robert Spranger, et al.The Journal of General Virology|October 18, 2005
The negative regulator of Borna disease virus polymerase is a non-structural proteinMalte Schwardt, Daniel Mayer, Ronald Frank, et al.Cellular Microbiology|June 19, 2007
Alteration of NF-kappaB activity leads to mitochondrial apoptosis after infection with pathological prion proteinSoizic Bourteele, Katja Oesterle, Andreas O Weinzierl, et al.Antiviral Research|March 4, 2024
The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistanceAndré Schreiber, Franziska Rodner, Nicole Oberberg, et al.Pageof 9